文献速递外周动脉疾病

外周动脉疾病血运重建后30天再入院风险因素与发生率的系统综述和荟萃分析

A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2019-01-01

报告再入院率范围为10.9%至30.0%,平均16.4%(95%CI 15.1%-17.9%)。荟萃分析发现女性、黑人种族、功能依赖、严重肢体缺血、急诊入院、高血压、心力衰竭、慢性肺病、糖尿病、慢性肾病、透析依赖、术后出血和术后脓毒症与再入院显著相关,吸烟与再入院风险降低相关。

要点

  • 约六分之一的外周动脉疾病血运重建患者在30天内再入院,平均再入院率为16.4%。
  • 严重肢体缺血、透析依赖和术后脓毒症是再入院的最强风险因素。
  • 识别高危患者有助于靶向干预以减少再入院。

核心结论

  • 约六分之一接受外周动脉疾病血运重建的患者在术后30天内再入院。
  • 本综述识别了多个再入院风险因素,可能有助于靶向干预以减少再入院。

研究设计与样本

  • 系统检索PubMed/Medline、Scopus、Web of Science、Cochrane Library和CINAHL从建库至2018年5月20日的文献。
  • 纳入报告外周动脉疾病患者血运重建后再入院率及至少一个风险因素统计评估的研究。
  • 数据采用随机效应模型进行合并。

主要发现

  • 报告再入院率范围为10.9%至30.0%,平均为16.4%(95%CI 15.1%-17.9%)。
  • 与再入院显著相关的风险因素包括:女性(OR 1.13,95%CI 1.05-1.21)、黑人种族(OR 1.36,95%CI 1.28-1.46)、功能依赖状态(OR 1.72,95%CI 1.43-2.06)。
  • 严重肢体缺血(OR 2.12,95%CI 1.72-2.62)、急诊入院(OR 1.75,95%CI 1.43-2.15)、高血压(OR 1.39,95%CI 1.26-1.54)、心力衰竭(OR 1.82,95%CI 1.50-2.20)。
  • 慢性肺病(OR 1.19,95%CI 1.08-1.32)、糖尿病(OR 1.47,95%CI 1.32-1.63)、慢性肾病(OR 1.93,95%CI 1.62-2.31)、透析依赖(OR 2.08,95%CI 1.75-2.48)。
  • 吸烟(OR 0.83,95%CI 0.78-0.89)、术后出血(OR 1.70,95%CI 1.23-2.35)、术后脓毒症(OR 4.13,95%CI 2.02-8.47)。

临床怎么用

  • 对于具有多个风险因素(如严重肢体缺血、透析依赖、心力衰竭、功能依赖)的外周动脉疾病患者,应考虑加强围手术期管理和出院后随访。
  • 针对可干预风险因素(如术后出血、术后脓毒症)的预防措施可能有助于减少再入院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Readmission to the hospital after revascularization for peripheral artery disease (PAD) is frequently reported. No consensus exists as to the exact frequency and risk factors for readmission. This review aimed to determine the incidence of and risk factors for 30-day readmission after revascularization for PAD. METHODS: PubMed/Medline (Ovid), Scopus, Web of Science, the Cochrane Library, and CINAHL were searched systematically from inception until May 20, 2018. Studies were eligible for inclusion if they included patients with diagnosed PAD undergoing revascularization and reported the readmission rate and a statistical evaluation of the association of at least one risk factor with readmission. Studies were excluded if data for other procedures could not be distinguished from revascularization. Two authors undertook study selection independently with the final inclusion decision resolved through consensus. The PRISMA and Meta-analyses of Observational Studies in Epidemiology guidelines were followed regarding data extraction and quality assessment, which was performed by two authors independently. Data were pooled using a random effects model. RESULTS: The primary outcome was readmission within 30 days of revascularization. Fourteen publications reporting the outcomes of 526,008 patients were included. Reported readmission rates ranged from 10.9% to 30.0% with a mean of 16.4% (95% confidence interval [CI], 15.1%-17.9%). Meta-analyses suggested the following risk factors had a significant association with readmission: female sex (odds ratio [OR], 1.13; 95% CI, 1.05-1.21), black race (OR, 1.36; 95% CI, 1.28-1.46), dependent functional status (OR, 1.72; 95% CI, 1.43-2.06), critical limb ischemia (OR, 2.12; 95% CI, 1.72-2.62), emergency admission (OR, 1.75; 95% CI, 1.43-2.15), hypertension (OR, 1.39; 95% CI, 1.26-1.54), heart failure (OR, 1.82; 95% CI, 1.50-2.20), chronic pulmonary disease (OR, 1.19; 95% CI, 1.08-1.32), diabetes (OR, 1.47; 95% CI, 1.32-1.63), chronic kidney disease (OR, 1.93; 95% CI, 1.62-2.31), dialysis dependence (OR, 2.08; 95% CI, 1.75-2.48), smoking (OR, 0.83; 95% CI, 0.78-0.89), postoperative bleeding (OR, 1.70; 95% CI, 1.23-2.35), and postoperative sepsis (OR, 4.13; 95% CI, 2.02-8.47). CONCLUSIONS: Approximately one in six patients undergoing revascularization for PAD are readmitted within 30 days of their procedure. This review identified multiple risk factors predisposing to readmission, which could potentially serve as a way to target interventions to reduce readmissions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Smith SL, Matthews EO, Moxon JV, et al. A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease. J Vasc Surg. 2019. PMID: 31445653. doi:10.1016/j.jvs.2019.01.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。